Extracellular Vesicle-Based Therapeutics: Current Advances and Future Perspectives
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 31 May 2025 | Viewed by 2892
Special Issue Editor
2. American Type Culture Collection, Manassas, VA 20110, USA
Interests: stem cell culture; stem cell-derived extracellular vesicles; 3D cell culture; regenerative medicine
Special Issue Information
Dear Colleagues,
The field of extracellular vesicles (EVs) and, more specifically, EV-based therapeutics, is expanding rapidly. Human and animal stem cells represent rich sources of EVs, and these EVs have demonstrated therapeutic applications across many different pathologies and tissue types due to their multi-functional reparative properties. Recent technological advances have further improved EV production/manufacturing, EV purification, and EV characterization. Importantly, these improvements can be leveraged to boost the therapeutic potential of EVs.
This Special Issue will focus on topics including, but not limited to, methods for enhanced EV production, including the isolation and characterization of EV subpopulations; strategies for maximizing EV potency and functionality; advanced assays for identification of EV-associated biological cargo; and various in vitro and in vivo models for cellular and tissue repair.
Dr. Heather Branscome
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles (EVs)
- stem cells
- mesenchymal stem cells
- in vitro cellular repair models
- animal models for repair and or/tissue regeneration
- cell-free therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
